TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Biofrontera ( (DE:B8FK) ) has issued an announcement.
Biofrontera AG is currently in negotiations with Biofrontera Inc. to make significant changes to their existing license and supply agreement. These discussions include reducing the transfer price of products sold in the US and exploring strategic options such as a potential merger, which could lead to a major shift in Biofrontera AG’s business model and strategic direction.
More about Biofrontera
Biofrontera AG operates in the pharmaceutical industry, focusing on the development and commercialization of dermatological products. The company is known for its innovative therapies and has a significant market presence in both Germany and the United States.
Average Trading Volume: 1,633
Technical Sentiment Signal: Sell
Current Market Cap: €15.19M
For detailed information about B8FK stock, go to TipRanks’ Stock Analysis page.